Highlights

  • ECT presented its strategy to commercialise Flash Joule Heating (FJH) for MXene production and PFAS destruction at Aussie Equities Day 2026.
  • The company has completed two preliminary FJH runs of 400g of MAX phase per batch, with a peak Yield of 31%.
  • ECT is targeting about 1kg per day of MXene production at Gator Point, Texas, once optimised.
  • A A$12.0 million Placement has been announced, with Tranche 2 subject to Shareholder approval at an EGM on 22 October 2026.

Environmental Clean Technologies Limited (ASX:ECT) has released an investor presentation outlining its plans to commercialise US-made MXenes for defence and advanced materials applications. The presentation, delivered by Non-Executive Director Lewis Utting, covers the company's use of Flash Joule Heating technology for both MXene production and PFAS destruction.

MXene Production Using Flash Joule Heating

MXenes are advanced two-dimensional materials. ECT said conventional production relies on hydrofluoric acid etching over about 48 to 72 hours, while its FJH process is claimed to take minutes without bulk acid handling. Based on initial test work, the company claims processing costs about 74% lower than chemical etching.

Two FJH runs have been completed using 400g of MAX phase per batch, achieving a peak yield of 31% from 30 to 60 minute runs. ECT described these results as preliminary, noting that further runs are needed to show repeatability at scale.

The company is targeting about 1kg per day of production at Gator Point, Texas, once optimised, and said this is a target rather than guidance. It also holds 4kg of US defence-aligned MAX phase precursor feedstock.

Defence and PFAS Market Opportunities

ECT highlighted potential defence uses for MXenes, including radar and EMI shielding, infrared signature management, rugged energy storage and sensing. The company noted that US Executive Order 14415 sourcing restrictions take effect on 1 January 2027. ECT stated that it has no contracted defence sales and that its Xenica sublicence is not a customer contract.

In PFAS destruction, the company's Rapid Electrothermal Mineralisation process achieved more than 99% removal of various PFAS in contaminated soils in lab testing. A 22kW pilot system, about 18 times the power of the lab prototype, has been built.

Capital Position and Upcoming Milestones

As at 29 September 2026, ECT had a Market Capitalisation of A$47.1 million and cash of A$1.7 million as at 30 June 2026. The company has announced a A$12.0 million placement, with Tranche 2 subject to shareholder approval.

The Xenica Acquisition and Tranche 2 of the placement are both subject to an extraordinary general meeting on 22 October 2026. The presentation noted that forward-looking statements, including production targets and milestone timing, may differ from actual outcomes.

Key Takeaways

  • ECT is positioning its FJH technology for US MXene production aimed at defence and advanced materials markets.
  • Early FJH runs are preliminary, and repeatability at scale is still to be demonstrated.
  • The company has no contracted defence sales at this stage.
  • A A$12.0 million placement and the Xenica acquisition depend on an EGM on 22 October 2026.